# Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma

> **NCT03573362** · NA · UNKNOWN · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 50 (estimated)

## Conditions studied

- Sarcoidosis
- Lymphoma
- Adenopathy Hilar

## Interventions

- **DEVICE:** ViziShot FLEX 19G needle
- **DEVICE:** Vizishot 22G needle (standard)

## Key facts

- **NCT ID:** NCT03573362
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03573362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03573362, "Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03573362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*